e-learning
resources
Virtual 2021
06.09.2021
Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metformin as an adjunct in treatment of Pulmonary Tuberculosis in Non-Diabetic patients.
S. Pothal (Sambalpur (Odisha), India), I. Samantaray (Sambalpur (Odisha), India), S. Biswal (Sambalpur (Odisha), India)
Source:
Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Session:
Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Session type:
Oral Presentation
Number:
1601
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pothal (Sambalpur (Odisha), India), I. Samantaray (Sambalpur (Odisha), India), S. Biswal (Sambalpur (Odisha), India). Metformin as an adjunct in treatment of Pulmonary Tuberculosis in Non-Diabetic patients.. 1601
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups.
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Innovative therapies in Pulmonary Hypertension
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016
Pulmonary Hypertension in Hemodialysis Patients
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Combination of sPESI and cardiac troponin in the outpatient treatment of pulmoner thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM)
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018
Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Tuberculosis therapy
Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK
Year: 2016
Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept